FR2926818B1 - siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE - Google Patents

siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE

Info

Publication number
FR2926818B1
FR2926818B1 FR0800492A FR0800492A FR2926818B1 FR 2926818 B1 FR2926818 B1 FR 2926818B1 FR 0800492 A FR0800492 A FR 0800492A FR 0800492 A FR0800492 A FR 0800492A FR 2926818 B1 FR2926818 B1 FR 2926818B1
Authority
FR
France
Prior art keywords
synthesis
rna interference
cationic sirna
sirna
cationic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0800492A
Other languages
English (en)
French (fr)
Other versions
FR2926818A1 (fr
Inventor
Jean Paul Behr
Mitsuhara Kotera
Nadege Pfender
Jean Serge Remy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0800492A priority Critical patent/FR2926818B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to BRPI0907494A priority patent/BRPI0907494A2/pt
Priority to CA2713075A priority patent/CA2713075A1/fr
Priority to EP09707000.7A priority patent/EP2250267B1/fr
Priority to KR1020107019289A priority patent/KR20100120293A/ko
Priority to NZ587117A priority patent/NZ587117A/xx
Priority to AU2009208646A priority patent/AU2009208646A1/en
Priority to US12/735,595 priority patent/US10927371B2/en
Priority to RU2010136047/10A priority patent/RU2010136047A/ru
Priority to JP2010544836A priority patent/JP2011511776A/ja
Priority to PCT/IB2009/050379 priority patent/WO2009095887A1/fr
Priority to CN200980107841XA priority patent/CN101960009A/zh
Publication of FR2926818A1 publication Critical patent/FR2926818A1/fr
Priority to IL207290A priority patent/IL207290A0/en
Application granted granted Critical
Publication of FR2926818B1 publication Critical patent/FR2926818B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0800492A 2008-01-30 2008-01-30 siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE Active FR2926818B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0800492A FR2926818B1 (fr) 2008-01-30 2008-01-30 siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE
PCT/IB2009/050379 WO2009095887A1 (fr) 2008-01-30 2009-01-30 siRNA CATIONIQUES, SYNTHÈSE ET UTILISATION POUR L'ARN INTERFÉRENCE
EP09707000.7A EP2250267B1 (fr) 2008-01-30 2009-01-30 siRNA CATIONIQUES, SYNTHÈSE ET UTILISATION POUR L'ARN INTERFÉRENCE
KR1020107019289A KR20100120293A (ko) 2008-01-30 2009-01-30 양이온성 ｓｉＲＮＡ, 합성 및 ＲＮＡ 간섭을 위한 용도
NZ587117A NZ587117A (en) 2008-01-30 2009-01-30 Cationic siRNAs, synthesis and use for RNA interference
AU2009208646A AU2009208646A1 (en) 2008-01-30 2009-01-30 Cationic siRNAs, synthesis and use for interfering RNA
BRPI0907494A BRPI0907494A2 (pt) 2008-01-30 2009-01-30 ácido rubonucleicos de pequena interferência (sirna) catiônicos, composições farmacêuticas, aplicação de ácidos rubonucleicos de pequena interferência (sirna) catiônicos e processo de síntese automatizado de um filamento de ácido rubonucleico de pequena interferência (sirna) catiônico.
RU2010136047/10A RU2010136047A (ru) 2008-01-30 2009-01-30 КАТИОННЫЕ siPНК, СИНТЕЗ И ПРИМЕНЕНИЕ В РНК-ИНТЕРФЕРЕНЦИИ
JP2010544836A JP2011511776A (ja) 2008-01-30 2009-01-30 ＲＮＡ干渉のためのカチオン性ｓｉＲＮＡ、合成及び使用
CA2713075A CA2713075A1 (fr) 2008-01-30 2009-01-30 Sirna cationiques, synthese et utilisation pour l'arn interference
CN200980107841XA CN101960009A (zh) 2008-01-30 2009-01-30 阳离子siRNA、合成以及用于RNA干扰的用途
US12/735,595 US10927371B2 (en) 2008-01-30 2009-01-30 Cationic siRNAs, synthesis and use for RNA interference
IL207290A IL207290A0 (en) 2008-01-30 2010-07-29 CATIONIC siRNAs, SYNTHESIS AND USE FOR INTERFERING RNA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800492A FR2926818B1 (fr) 2008-01-30 2008-01-30 siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE

Publications (2)

Publication Number Publication Date
FR2926818A1 FR2926818A1 (fr) 2009-07-31
FR2926818B1 true FR2926818B1 (fr) 2012-04-06

Family

ID=39683957

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0800492A Active FR2926818B1 (fr) 2008-01-30 2008-01-30 siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE

Country Status (13)

Country Link
US (1) US10927371B2 (enExample)
EP (1) EP2250267B1 (enExample)
JP (1) JP2011511776A (enExample)
KR (1) KR20100120293A (enExample)
CN (1) CN101960009A (enExample)
AU (1) AU2009208646A1 (enExample)
BR (1) BRPI0907494A2 (enExample)
CA (1) CA2713075A1 (enExample)
FR (1) FR2926818B1 (enExample)
IL (1) IL207290A0 (enExample)
NZ (1) NZ587117A (enExample)
RU (1) RU2010136047A (enExample)
WO (1) WO2009095887A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325054B2 (en) * 2005-12-15 2013-05-02 Centre National De La Recherche Scientifique (Cnrs) Cationic oligonucleotides, automated methods for preparing same and their uses
WO2015015498A1 (en) * 2013-07-31 2015-02-05 Qbi Enterprises Ltd. Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
AU2016226418B2 (en) 2015-03-02 2022-05-26 Synthetic Genomics, Inc. Regulatory elements from labyrinthulomycetes microorganisms
US10633454B2 (en) 2016-11-01 2020-04-28 Conagen Inc. Expression of modified glycoproteins and glycopeptides
EP3535385A4 (en) * 2016-11-01 2020-06-17 Conagen Inc. EXPRESSION OF MODIFIED GLYCOPROTEINS AND GLYCOPEPTIDES
CN106498072B (zh) * 2016-11-24 2019-09-10 青岛千卓分子生物科技有限公司 一种液态产品中外源dna内标物的保护方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
EP1013770A1 (en) 1998-12-23 2000-06-28 Université Louis Pasteur de Strasbourg Non-viral transfection vector
DE10207177A1 (de) 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
US20040019008A1 (en) 2002-05-28 2004-01-29 Lewis David L. Compositions and processes using siRNA, amphipathic compounds and polycations
JP2004137143A (ja) 2002-08-21 2004-05-13 Fuji Photo Film Co Ltd 有機変性層状珪酸塩及びその組成物
EP1585756B1 (en) * 2002-11-26 2010-04-21 University of Massachusetts Delivery of sirnas
EP1638919B1 (en) * 2003-06-18 2012-09-26 Biolab Ltd. Sphingolipids polyalkylamines conjugates
WO2005060697A2 (en) * 2003-12-19 2005-07-07 Chiron Corporation Cell transfecting formulations of small interfering rna, related compositions and methods of making and use
US20060073505A1 (en) * 2004-09-21 2006-04-06 Isis Pharmaceuticals, Inc. Oligomeric compounds effecting drosha-mediated cleavage
JP2008519053A (ja) * 2004-11-04 2008-06-05 アンディーノ，ラウル 小さい干渉ＲＮＡ（ｓｉＲＮＡ）のポリアミン共役体の合成及びそれによって形成された共役体
CA2587962A1 (en) * 2004-11-17 2006-06-08 University Of Maryland, Baltimore Highly branched hk peptides as effective carriers of sirna
AU2006325054B2 (en) 2005-12-15 2013-05-02 Centre National De La Recherche Scientifique (Cnrs) Cationic oligonucleotides, automated methods for preparing same and their uses
EP1844772A1 (en) 2006-04-06 2007-10-17 Polyplus-Transfection SA Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
EP2992875A1 (en) * 2006-04-20 2016-03-09 Silence Therapeutics GmbH Lipoplex formulations for specific delivery to vascular endothelium

Also Published As

Publication number Publication date
AU2009208646A1 (en) 2009-08-06
JP2011511776A (ja) 2011-04-14
US10927371B2 (en) 2021-02-23
CA2713075A1 (fr) 2009-08-06
EP2250267B1 (fr) 2016-09-14
CN101960009A (zh) 2011-01-26
EP2250267A1 (fr) 2010-11-17
KR20100120293A (ko) 2010-11-15
WO2009095887A1 (fr) 2009-08-06
IL207290A0 (en) 2010-12-30
FR2926818A1 (fr) 2009-07-31
NZ587117A (en) 2012-09-28
BRPI0907494A2 (pt) 2019-09-24
RU2010136047A (ru) 2012-03-10
US20110118331A1 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
EP2294213A4 (en) METHOD FOR MODULATING CREB EXPRESSION
EP2438168A4 (en) POLYNUCLEOTIDES FOR MULTIVALENT RNA INTERFERENCES, COMPOSITIONS THEREOF AND METHOD OF USE THEREOF
EP2198039A4 (en) MODIFIED MICROORGANISMS FOR THE MANUFACTURE OF ISOPROPANOL
EP2438989A4 (en) ASYMMETRIC HYDROGENATION CATALYST
PL2476689T3 (pl) Tiowęglowe grupy zabezpieczające do syntezy RNA
BRPI0923274A2 (pt) sistema de lavagem de louca contendo amido cationico
EP2324045A4 (en) PHOTOVERNETIC NUCLEIC ACID HYDROGEL
EP2245927A4 (en) PESTICIDE SPRAY
EP2283132A4 (en) SELECTIVE 5-LIGATION TAGGING OF RNA
FR2954857B3 (fr) Accumulateur ion-lithium specifique pour l'allumage de motos
FR2930235B1 (fr) Mat de suspension pour turbomoteur.
BRPI0923048A2 (pt) "composto de aminopirazol".
EP2404470A4 (en) BACON MODE FOR WIRELESS COMMUNICATION
EP2607482A4 (en) SOLUTION TO RNA EXTRACTION
EP2242580A4 (en) ZIEGLER-NATTA CATALYST
BR112012010591A2 (pt) "conjugado de moléculas, ácido nucleico e método pe produção de conjugado de móleculas"
FR2926818B1 (fr) siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE
EP2232459A4 (en) VOICE SOFTWARE FOR NAVIGATION DATA
EP2543437A4 (en) HOMOGENEOUS ASYMMETRIC HYDROGENATION CATALYST
EP2300488A4 (en) CELL LYLE REAGENT FOR ISOLATION OF RNA
EP2333109A4 (en) COMPOSITION FOR THE DETECTION OF RNA
EP2262365A4 (en) USE OF '-THIO-2'-DEOXYNUCLEOSIDES AS ACTIVE AGENTS AGAINST ORTHOPOXVIRUS
FR2932101B1 (fr) Utilisation de supports soufres pour le reformage catalytique.
BR112012012449A2 (pt) "processo para preparar 2-isoxazolinas 5,5-dissubstituídas"
FR2908600B1 (fr) Capsicum microencapsule, procede pour sa preparation, et utilisation

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20120511

Owner name: UNIVERSITE DE STRASBOURG, FR

Effective date: 20120511

PLFP Fee payment

Year of fee payment: 9

CL Concession to grant licences

Name of requester: POLYPLUS TRANSFECTION, FR

Effective date: 20160513

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18